Menu
GeneBe

chr17-29576104-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_014030.4(GIT1):​c.1639G>T​(p.Val547Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,516 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. V547V) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

GIT1
NM_014030.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.688
Variant links:
Genes affected
GIT1 (HGNC:4272): (GIT ArfGAP 1) Enables gamma-tubulin binding activity. Involved in positive regulation of microtubule nucleation and regulation of cytokinesis. Located in several cellular components, including focal adhesion; microtubule cytoskeleton; and mitochondrion. Implicated in attention deficit hyperactivity disorder. Biomarker of Huntington's disease. [provided by Alliance of Genome Resources, Apr 2022]
ABHD15-AS1 (HGNC:49685): (ABHD15 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, GIT1
BP4
Computational evidence support a benign effect (MetaRNN=0.091649115).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GIT1NM_014030.4 linkuse as main transcriptc.1639G>T p.Val547Leu missense_variant 15/20 ENST00000225394.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GIT1ENST00000225394.8 linkuse as main transcriptc.1639G>T p.Val547Leu missense_variant 15/201 NM_014030.4 A1Q9Y2X7-1
ABHD15-AS1ENST00000581474.1 linkuse as main transcriptn.153+15405C>A intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461516
Hom.:
0
Cov.:
33
AF XY:
0.00000138
AC XY:
1
AN XY:
727052
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 26, 2023The c.1666G>T (p.V556L) alteration is located in exon 16 (coding exon 16) of the GIT1 gene. This alteration results from a G to T substitution at nucleotide position 1666, causing the valine (V) at amino acid position 556 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.059
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
15
DANN
Benign
0.97
DEOGEN2
Benign
0.093
T;.;.;.;T
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.49
N
LIST_S2
Uncertain
0.88
D;D;D;D;D
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.092
T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
N;.;.;.;.
MutationTaster
Benign
0.83
N;N;N;N
PrimateAI
Uncertain
0.57
T
PROVEAN
Benign
-0.45
N;N;.;.;.
REVEL
Benign
0.063
Sift
Benign
0.36
T;T;.;.;.
Sift4G
Benign
0.85
T;T;T;T;T
Polyphen
0.0030
B;B;.;.;.
Vest4
0.39
MutPred
0.34
Gain of relative solvent accessibility (P = 0.0166);.;.;Gain of relative solvent accessibility (P = 0.0166);.;
MVP
0.53
MPC
0.20
ClinPred
0.12
T
GERP RS
3.2
Varity_R
0.036
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-27903122; COSMIC: COSV56403807; COSMIC: COSV56403807; API